The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Heterogeneity of Type I diabetes: analysis of monozygotic twins in Great Britain and the United States
Open accessAbstract
Aims To determine the risk, hazard rate and factors affecting progression to diabetes in monozygotic twins of patients with Type I (insulin-dependent) diabetes mellitus.Methods Prospective analysis was done of two cohorts of non-diabetic monozygotic twins of patients with Type I diabetes from Great Britain (n = 134) and the United States (n = 53).Results The diabetes-free survival analysis was similar between both cohorts (p = 0.6). The combined survival analysis (n = 187, median follow-up = 17.7 years, range = 0.01-57) at 40 years of discordance estimated a 39% probability of diabetes for the initially discordant twin. Survival analysis with left truncation of data estimated that probability to be 50%. For twins who became concordant (n = 47), the median discordance time was 4.2 years (range 0.4 to 39), exceeding 15 years in 23.4%. Twins of probands diagnosed at 24 years of age or younger had a 38% probability of diabetes by 30 years of discordance, compared with 6% for twins of probands diagnosed after 24 years of age (p = 0.004). The twins of probands diagnosed before 15 years of age had the highest diabetes hazard rate in the first discordance year, decreasing thereafter. By survival analysis, diabetes risk was higher in twins who were heterozygous for DR3-DQ2 and DR4-DQ8 than in twins with neither DR3-DQ2 nor DR4-DQ8 (p < 0.05).Conclusion/interpretation Monozygotic twins of patients with Type I diabetes from two different countries had similar rates of progression to diabetes. Whereas most twins did not develop diabetes, 25% of the twins who progressed did so after more than 14 years of discordance. An age-related heterogeneity was observed, with higher progression to diabetes for twins of patients diagnosed at a younger age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence suggests that, compared with childhood-onset T1DM, adult-onset (ages ≥18 years) disease has a lower frequency of high-risk HLA types54, lower concordance rates in twins55, more protective genotypes56, lower genetic risk scores57 and lower overall genetic load (with minor differences in HLA class II gene associations)56.”
From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [55]
Experimental — accuracy not yet measuredIn the citing paper
“Monozygotic twins have a concordance rate of > 60% if followed long enough47 whereas dizygotic twins have a concordance rate of 6% to 10%.”
From Epidemiology of type 1 diabetes (2010) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Survival Analysis Techniques for Censored and Truncated Data
Rao, M. B., Klein, J. P., & Moeschberger, M. L. (1998) · Technometrics · doi:10.2307/1270658 · Cited by 3,617
The expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,603
A twin-pronged attack on complex traits
Martin, N. G., Boomsma, D. I., & Machin, G. A. (1997) · Nature Genetics · doi:10.1038/ng1297-387 · Cited by 654
A Population-Based Study of Multiple Sclerosis in Twins
Ebers, G. C., Bulman, D. E., Sadovnick, A. D., Paty, D. W., Warren, S., Hader, W. J., Murray, T. J., Seland, T. P., Duquette, P., Grey, T., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152603 · Cited by 637
Kyvik, K. O., Green, A., & Beck‐Nielsen, H. (1995) · BMJ · doi:10.1136/bmj.311.7010.913 · Cited by 357
Concordance in twins: methods and interpretation.
Smith, C. S. (1974) · PubMed · Cited by 233
Srikanta, S., Ganda, O. P., Eisenbarth, G. S., & Soeldner, J. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198302103080607 · Cited by 224
Self-citationPugliese, A., Gianani, R., Moromisato, R., Awdeh, Z., Alper, C. A., Erlich, H. A., Jackson, R. A., & Eisenbarth, G. S. (1995) · Diabetes · doi:10.2337/diab.44.6.608 · Cited by 207
Self-citationType I Diabetes Mellitus in Monozygotic Twins: Chronic Progressive Beta Cell Dysfunction
Srikanta, S., GANDA, O. P., JACKSON, R. A., Gleason, R. E., KALDANY, A., Garovoy, M. R., MILFORD, E. L., Carpenter, C. B., Soeldner, J. S., & Eisenbarth, G. S. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-3-320 · Cited by 167
Self-citationKumar, D., Gemayel, N. S., Deapen, D., Kapadia, D., Yamashita, P. H., Lee, M., Dwyer, J. H., Roy‐Burman, P., Bray, G. A., & Mack, T. M. (1993) · Diabetes · doi:10.2337/diab.42.9.1351 · Cited by 158
Flagged first, then by citations
Cited by
Sorted by citations
Insel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216
Epidemiology of type 1 diabetes
Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.011 · Cited by 1,092
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Autoimmune Polyendocrine Syndromes
Eisenbarth, G. S., & Gottlieb, P. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030158 · Cited by 669
Self-citationGut microbiota, obesity and diabetes
Patterson, E., Ryan, P. M., Cryan, J. F., Dinan, T. G., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133285 · Cited by 552
Concannon, P., Rich, S. S., & Nepom, G. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0808284 · Cited by 510
Genetic Liability of Type 1 Diabetes and the Onset Age Among 22,650 Young Finnish Twin Pairs
Harjutsalo, V., Kaprio, J. A., Kinnunen, L., Koskenvuo, M. J., & Tuomilehto, J. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1052 · Cited by 392
Concordance for islet autoimmunity among monozygotic twins
Redondo, M. J., Jeffrey, J., Fain, P. R., Eisenbarth, G. S., & Orban, T. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0805398 · Cited by 353
Self-citationRakyan, V. K., Beyan, H., Down, T. A., Hawa, M. I., Maslau, S., Aden, D., Daunay, A., Busato, F., Mein, C. A., Manfras, B. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002300 · Cited by 347
Self-citationA Genome-Wide Meta-Analysis of Six Type 1 Diabetes Cohorts Identifies Multiple Associated Loci
Bradfield, J. P., Qu, H., Wang, K., Zhang, H., Abou‐Sleiman, P. M., Kim, C. E., Mentch, F. D., Qiu, H., Glessner, J., Thomas, K., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002293 · Cited by 348
Steck, A. K., & Rewers, M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.148221 · Cited by 337
The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes
Pearson, J. A., Wong, F. S., & Li, W. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.019 · Cited by 320
The Emerging Global Epidemic of Type 1 Diabetes
Tuomilehto, J. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0433-5 · Cited by 292
Th17 Cells in Immunity and Autoimmunity
Bedoya, S. K., Lam, B. K., Lau, K., & Larkin, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/986789 · Cited by 293
Twin studies in autoimmune disease: Genetics, gender and environment
Bogdanos, D. P., Smyk, D. S., Rigopoulou, E. I., Mytilinaiou, M. G., Heneghan, M. A., Selmi, C. F., & Gershwin, M. E. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.11.003 · Cited by 294
The use of animal models in the study of diabetes mellitus.
Chatzigeorgiou, A., Halapas, A., Kalafatakis, K., & Kamper, E. F. (2009) · PubMed · Cited by 252
Adult-Onset Type 1 Diabetes: Current Understanding and Challenges
Leslie, R. D., Evans‐Molina, C., Freund-Brown, J., Buzzetti, R., Dabelea, D., Gillespie, K. M., Goland, R., Jones, A. G., Kacher, M. L., Phillips, L. S., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0770 · Cited by 288
Self-citationHuber, A. K., Menconi, F., Corathers, S. D., Jacobson, E. M., & Tomer, Y. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0015 · Cited by 235
Rat Models of Type 1 Diabetes: Genetics, Environment, and Autoimmunity
Mordes, J. P., Bortell, R., Blankenhorn, E. P., Rossini, A. A., & Greiner, D. L. (2004) · ILAR Journal · doi:10.1093/ilar.45.3.278 · Cited by 217
Redondo, M. J., Steck, A. K., & Pugliese, A. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12597 · Cited by 216
Self-citationOxidative Stress Biology and Cell Injury During Type 1 and Type 2 Diabetes Mellitus
Maiese, K., Morhan, S. D., & Chong, Z. Z. (2007) · Current Neurovascular Research · doi:10.2174/156720207779940653 · Cited by 213
Selective IgA Deficiency in Autoimmune Diseases
Wang, N., Shen, N., Vyse, T. J., Anand, V., Gunnarson, I., Sturfelt, G. K., Rantapää‐Dahlqvist, S., Elvin, K., Truedsson, L., Andersson, B. A., et al. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00195 · Cited by 210
Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models.
Todd, J. A., & Wicker, L. (2001) · Immunity · doi:10.1016/s1074-7613(01)00202-3 · Cited by 239
Mechanistic Insights Into Diabetes Mellitus and Oxidative Stress
Maiese, K., Chong, Z. Z., & Shang, Y. C. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781058968 · Cited by 186
REDONDO, M. J., Geyer, S. M., Steck, A. K., Sharp, S. A., Wentworth, J. M., Weedon, M. N., Antinozzi, P. A., Sosenko, J. M., Atkinson, M. A., Pugliese, A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0087 · Cited by 179
Self-citationIncreased DNA methylation variability in type 1 diabetes across three immune effector cell types
Paul, D. S., Teschendorff, A. E., Dang, M. N., Lowe, R., Hawa, M. I., Ecker, S., Beyan, H., Cunningham, S. L., Fouts, A., Ramelius, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms13555 · Cited by 177
Self-citationInhibition of Type 1 Diabetes Correlated to a Lactobacillus johnsonii N6.2-Mediated Th17 Bias
Lau, K., Benitez, P., Ardissone, A. N., Wilson, T. D., Collins, E. L., Lorca, G. L., Li, N., Sankar, D., Wasserfall, C. H., Neu, J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001864 · Cited by 158
DNA methylation and its role in the pathogenesis of diabetes
Bansal, A., & Pinney, S. E. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12521 · Cited by 166
Control of T Cell-mediated Autoimmunity by Metabolite Flux to N-Glycan Biosynthesis
Grigorian, A., Lee, S., Tian, W., Chen, I.-J., Gao, G., Mendelsohn, R., Dennis, J. W., & Demetriou, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701890200 · Cited by 151
Ma, W.-T., Chang, C. C.-C., Gershwin, M. E., & Lian, Z. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.003 · Cited by 146
Li, W., Peng, J., Li, Z., & Wong, F. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3173 · Cited by 143
Drescher, K. M., Kono, K., Bopegamage, S., Carson, S. D., & Tracy, S. (2004) · Virology · doi:10.1016/j.virol.2004.06.049 · Cited by 137
Genome–virome interactions: examining the role of common viral infections in complex disease
Foxman, E. F., & Iwasaki, A. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2541 · Cited by 138
TLR Activation Synergizes with Kilham Rat Virus Infection to Induce Diabetes in BBDR Rats
Zipris, D., Lien, E., Xie, J. X., Greiner, D. L., Mordes, J. P., & Rossini, A. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.131 · Cited by 129
The stages of type 1A diabetes: 2005
Gianani, R., & Eisenbarth, G. S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00248.x · Cited by 129
Self-citationMolecular Mechanisms in Autoimmune Type 1 Diabetes: a Critical Review
Xie, Z., Chang, C., & Zhou, Z. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8422-2 · Cited by 127
Genetic linkage and association studies of Type I diabetes: challenges and rewards
Field, L. L. (2002) · Diabetologia · doi:10.1007/s125-002-8241-7 · Cited by 117
Type 1 Diabetes and Latent Autoimmune Diabetes in Adults: One End of the Rainbow
Leslie, R. D. G., Williams, R., & Pozzilli, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1623 · Cited by 142
Self-citationGenetic epidemiology of type 1 diabetes
Hirschhorn, J. N. (2003) · Pediatric Diabetes · doi:10.1034/j.1399-5448.2001.00013.x · Cited by 112
Molecular aspects of type 1 diabetes
Kelly, M. A. (2003) · Molecular Pathology · doi:10.1136/mp.56.1.1 · Cited by 107
Golden, B. K., Levin, L., Ban, Y., Concepcion, E., Greenberg, D. A., & Tomer, Y. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2236 · Cited by 105
The prenatal environment and type 1 diabetes
Stene, L. C., & Gale, E. A. M. (2013) · Diabetologia · doi:10.1007/s00125-013-2929-6 · Cited by 102
Villano, M. J. B., Huber, A. K., Greenberg, D. A., Golden, B. K., Concepcion, E., & Tomer, Y. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2193 · Cited by 100
Zipris, D., Lien, E., Nair, A., Xie, J. X., Greiner, D. L., Mordes, J. P., & Rossini, A. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.693 · Cited by 99
Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes
Leslie, R. D., Ronald, C. W., Franks, P. W., Nadeau, K. J., Pearson, E. R., & REDONDO, M. J. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00159-6 · Cited by 112
Self-citationGhodke‐Puranik, Y., Joshi, K., Chopra, A., & Patwardhan, B. (2005) · European Journal of Epidemiology · doi:10.1007/s10654-005-5081-x · Cited by 92
Dealing with death data: individual hazards, mortality and bias
Zens, M. S., & Peart, D. R. (2003) · Trends in Ecology & Evolution · doi:10.1016/s0169-5347(03)00096-x · Cited by 91
Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes
Waldron-Lynch, F., & Herold, K. C. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3402 · Cited by 96
Immunopathology of the human pancreas in type-I diabetes
Richardson, S. J., O’Connell, A., Bone, A. J., Morgan, N. G., & Foulis, A. K. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-010-0205-0 · Cited by 88
Viral infections and molecular mimicry in type 1 diabetes
Coppieters, K. T., Wiberg, A., & von Herrath, M. G. (2012) · Apmis · doi:10.1111/apm.12011 · Cited by 90
Gut microbial metabolites alter IgA immunity in type 1 diabetes
Huang, J., Pearson, J. A., Peng, J., Hu, Y., Sha, S., Xing, Y., Huang, G., Li, X., Hu, F., Xie, Z., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.135718 · Cited by 92
Hu, Y., Peng, J., Tai, N., Hu, C., Zhang, X., Wong, F. S., & Li, W. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500884 · Cited by 85
Michels, A. W., Zhang, L., Khadra, A., Kushner, J. A., REDONDO, M. J., & Pietropaolo, M. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12299 · Cited by 87
Self-citationLeete, P., Mallone, R., Richardson, S. J., Sosenko, J. M., REDONDO, M. J., & Evans‐Molina, C. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1083-4 · Cited by 83
Self-citationUtility of genetic risk scores in type 1 diabetes
Luckett, A. M., Weedon, M. N., Hawkes, G., Leslie, R. D., Oram, R. A., & Grant, S. F. A. (2023) · Diabetologia · doi:10.1007/s00125-023-05955-y · Cited by 80
Self-citationThe genetic architecture of type 1 diabetes mellitus
Nyaga, D. M., Vickers, M. H., Jefferies, C., Perry, J. K., & O'Sullivan, J. M. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.06.002 · Cited by 79
Genes Involved in Type 1 Diabetes: An Update
Bakay, M. A., Pandey, R., & Hakonarson, H. H. (2013) · Genes · doi:10.3390/genes4030499 · Cited by 80
Zipris, D. (2009) · Clinical Immunology · doi:10.1016/j.clim.2008.12.011 · Cited by 75
SUMO4 and its role in type 1 diabetes pathogenesis
Wang, C., & She, J. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.797 · Cited by 75
Rani, P. S., Sechi, L. A., & Ahmed, N. (2010) · Gut Pathogens · doi:10.1186/1757-4749-2-1 · Cited by 74
Greiner, D. L., Rossini, A. A., & Mordes, J. P. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5075 · Cited by 74
Age-Dependent Influences on the Origins of Autoimmune Diabetes
Leslie, R. D., & Castelli, M. D. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3033 · Cited by 72
Self-citationSlattery, J. M., MacFabe, D. F., & Frye, R. E. (2016) · Clinical Medicine Insights Pediatrics · doi:10.4137/cmped.s38338 · Cited by 72
Enteroviruses, type 1 diabetes and hygiene: a complex relationship
Tracy, S., Drescher, K. M., Jackson, J. D., Kim, K., & Kono, K. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.639 · Cited by 70
Intestinal permeability in type 1 diabetes: An updated comprehensive overview
Mønsted, M. Ø., Falck, N. D., Pedersen, K., Buschard, K., Holm, L. J., & Haupt‐Jorgensen, M. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102674 · Cited by 74
The Genetic Architecture of Type 1 Diabetes
Jerram, S. T., & Leslie, R. D. (2017) · Genes · doi:10.3390/genes8080209 · Cited by 80
Self-citationPathogenesis of type 1 diabetes: lessons from natural history studies of high‐risk individuals
Nokoff, N., & Rewers, M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12021 · Cited by 71
The Genetic Contribution to Type 1 Diabetes
Bakay, M. A., Pandey, R., Grant, S. F. A., & Hakonarson, H. H. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1235-1 · Cited by 72
Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents
Ferrara-Cook, C. T., Geyer, S. M., Evans‐Molina, C., Libman, I. M., BECKER, D. J., Gitelman, S. E., REDONDO, M. J., & the Type 1 Diabetes TrialNet Study Group (2020) · Diabetes Care · doi:10.2337/dc19-1167 · Cited by 67
Self-citationAlberto, P. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00082-3 · Cited by 67
A role for innate immunity in type 1 diabetes?
Beyan, H., Buckley, L. R., Yousaf, N., Londei, M., & Leslie, R. D. G. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.341 · Cited by 66
Self-citationAnsari, M. A., Chauhan, W., Shoaib, S., Alyahya, S. A., Ali, M., Ashraf, H., Alomary, M. N., & Al-Suhaimi, E. A. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01369-3 · Cited by 66
The natural history of type 1A diabetes
Eisenbarth, G. S., & Jeffrey, J. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000200002 · Cited by 64
Self-citationGroup B Coxsackievirus Diabetogenic Phenotype Correlates with Replication Efficiency
Kanno, T., Kim, K., Kono, K., Drescher, K. M., Chapman, N. M., & Tracy, S. (2006) · Journal of Virology · doi:10.1128/jvi.02361-05 · Cited by 63
The Challenge of Type 1 Diabetes Mellitus
Eiselein, L., Schwartz, H. J., & Rutledge, J. (2004) · ILAR Journal · doi:10.1093/ilar.45.3.231 · Cited by 64
Immune recognition and response to the intestinal microbiome in type 1 diabetes
Paun, A., Yau, C., & Danska, J. S. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.02.004 · Cited by 67
Autoimmune Diabetes and the Circle of Tolerance
Rossini, A. A. (2004) · Diabetes · doi:10.2337/diabetes.53.2.267 · Cited by 62
Glycotoxin and Autoantibodies Are Additive Environmentally Determined Predictors of Type 1 Diabetes
Beyan, H., Riese, H., Hawa, M. I., Beretta, G., Davidson, H. W., Hutton, J. C., Burger, H., Schlosser, M., Snieder, H., Boehm, B. O., et al. (2012) · Diabetes · doi:10.2337/db11-0971 · Cited by 60
Self-citationLongitudinal DNA methylation differences precede type 1 diabetes
Johnson, R. K., Vanderlinden, L. A., Dong, F., Carry, P. M., Seifert, J. A., Waugh, K., Shorrosh, H., Fingerlin, T. E., Frohnert, B. I., Yang, I. V., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60758-0 · Cited by 63
The epidemiology of type 1 diabetes mellitus in older adults
Tomic, D., Harding, J. L., Jenkins, A. J., Shaw, J. E., & Magliano, D. J. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01046-z · Cited by 58
“…with childhood-onset T1DM, adult-onset (ages ≥18 years) disease has a lower frequency of high-risk HLA types 54 , lower concordance rates in twins 55 , more protective genotypes 56 , lower genetic risk scores 57 and lower overall genetic load (with minor differences in HLA class II gene…”
Cross-reactive public TCR sequences undergo positive selection in the human thymic repertoire
Maharlooei, M. K., Obradović, A., Misra, A., Motwani, K., Hölzl, M. A., Seay, H. R., DeWolf, S., Nauman, G., Danzl, N. M., Li, H., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124358 · Cited by 60
Mechanisms of Beta Cell Dysfunction Associated With Viral Infection
Petzold, A., Solimena, M., & Knoch, K.-P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0654-x · Cited by 58
Meah, F., Dimeglio, L., Greenbaum, C., Blum, J., Sosenko, J. M., Pugliese, A., Geyer, S., Xu, P., & Evans-Molina, C. (2016) · Diabetologia · doi:10.1007/s00125-016-3924-5 · Cited by 47
Innate immunity and its role in type 1 diabetes
Zipris, D. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283073a46 · Cited by 53
Interplay between PTPN22 C1858T polymorphism and cow's milk formula exposure in type 1 diabetes
Lempainen, J., Vaarala, O., Mäkelä, M., Veijola, R., Simell, O., Knip, M., Hermann, R., & Ilonen, J. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.04.003 · Cited by 53
Type 1 diabetes and gut microbiota: Friend or foe?
Hu, C., Wong, F. S., & Li, W. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.02.006 · Cited by 55
Disease-Modifying Therapies in Type 1 Diabetes: A Look into the Future of Diabetes Practice
Greenbaum, C. J., VanBuecken, D., & Lord, S. M. (2019) · Drugs · doi:10.1007/s40265-018-1035-y · Cited by 56
Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes.
Eisenbarth, G., Moriyama, H., Robles, D., Liu, E., Yu, L.-P., Babu, S., Redondo, M., Gottlieb, P., Wegmann, D., & Rewers, M. (2002) · Autoimmunity Reviews · doi:10.1016/s1568-9972(02)00035-6 · Cited by 64
Self-citationGut microbiota and metabolites in the pathogenesis of endocrine disease
Fenneman, A. C., Rampanelli, E., Yin, Y. S., Ames, J., Blaser, M. J., Fliers, E., & Nieuwdorp, M. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190686 · Cited by 51
A roadmap of the generation of neoantigens as targets of the immune system in type 1 diabetes
Roep, B. O., Kracht, M. J. L., van Lummel, M., & Zaldumbide, A. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.09.007 · Cited by 51
Antibiotics, gut microbiota, environment in early life and type 1 diabetes
Hu, Y., Wong, F. S., & Li, W. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.034 · Cited by 50
Further Evidence of a Primary, Causal Association of the PTPN22 620W Variant With Type 1 Diabetes
Żołędziewska, M., Perra, C., Orrù, V., Moi, L., Frongia, P., Congia, M., Bottini, N., & Cucca, F. (2007) · Diabetes · doi:10.2337/db07-0289 · Cited by 49
Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis
REDONDO, M. J., Oram, R. A., & Steck, A. K. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0961-5 · Cited by 53
Self-citationDNA Methylation Patterning and the Regulation of Beta Cell Homeostasis
Parveen, N., & Dhawan, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.651258 · Cited by 48
Extreme genetic risk for type 1A diabetes in the post-genome era
Baschal, E. E., & Eisenbarth, G. S. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.03.003 · Cited by 48
Self-citationHolm, L. J., Haupt‐Jorgensen, M., Larsen, J., Giacobini, J. D., Bilgin, M., & Buschard, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194414 · Cited by 50
Novel Avenues of Drug Discovery and Biomarkers for Diabetes Mellitus
Maiese, K., Chong, Z. Z., Shang, Y., & Hou, J. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010362904 · Cited by 46
Characterization of the T-Cell Response to Coxsackievirus B4
Varela‐Calviño, R., Ellis, R., Sgarbi, G., Dayan, C. M., & Peakman, M. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1745 · Cited by 46
Low zinc in drinking water is associated with the risk of type 1 diabetes in children
Samuelsson, U., Oikarinen, S., Hyöty, H., & Ludvigsson, J. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00678.x · Cited by 44
Impact of genetic and non‐genetic factors in type 1 diabetes
Hawa, M. I., Beyan, H., Buckley, L. R., & Leslie, R. D. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10339 · Cited by 42
Self-citation
Metadata
- Authors
- Redondo, M. J., Yu, L., Hawa, M., Mackenzie, T., Pyke, D. A., Eisenbarth, G. S., & Leslie, R. D. G.
- Affiliations
- University of Colorado Health (US)
- St Bartholomew's Hospital (GB)
- University of Colorado Denver (US)
- Venue
- Diabetologia
- Published
- 2001-03-09
- Volume
- 44
- Issue
- 3
- Pages
- 354-362
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1985484102
- Cited by
- 322
- References
- 27
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 8 · 2023: 16 · 2022: 8 · 2021: 15 · 2020: 15 · 2019: 14 · 2018: 15 · 2017: 14 · 2016: 13 · 2015: 13 · 2014: 8 · 2013: 15 · 2012: 9
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 32083-16)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 1 diabetes, monozygotic twins, discordant twins, disease progression, diabetes risk, age at diagnosis, HLA-DR3-DQ2, HLA-DR4-DQ8, HLA heterozygosity, twin concordance
- MeSH terms
- Adolescent, Adult, Aged, Child, Child, Preschool, Diabetes Mellitus, Type 1, Diseases in Twins, Female, United Kingdom, Histocompatibility Testing, Humans, Infant, Male, Middle Aged, Polymorphism, Genetic, Time Factors, Twins, Monozygotic, United States, Proportional Hazards Models, Age of Onset, Disease-Free Survival, Microsatellite Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
